PMC:7796052 / 539-684 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":23,"end":33},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D020849"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"radykinin antagonists, raloxifene was identified as prospective compound in a virtual screening process. The pharmacodynamics profile of raloxife"}